AxoGen, Inc. (AXGN) vs TransMedics Group, Inc. (TMDX)
AxoGen, Inc. and TransMedics Group, Inc. are both Medical Devices companies. TransMedics Group, Inc. is the larger, with a market value of $2.9B against $2.5B — 1.1× the size. AxoGen, Inc. has negative trailing earnings, so its P/E is not meaningful; TransMedics Group, Inc. trades at 19.3×. TransMedics Group, Inc. grew revenue faster over the last twelve months: 25.8% against 23.6%. TransMedics Group, Inc. has the higher net margin (22.7% vs −13.4%) and the higher return on invested capital (5.62% vs −4.99%). Across the 19 metrics below, TransMedics Group, Inc. leads on 17 and AxoGen, Inc. on 2.
Valuation
Profitability
| Metric | AXGN | TMDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.56% | 58.69% | 56.01% |
| Operating margin | (5.12%) | 12.21% | (15.03%) |
| Net margin | (13.36%) | 22.69% | (20.40%) |
| Free cash flow margin | 2.59% | 11.82% | (7.24%) |
| Return on equity | (18.21%) | 36.28% | (15.32%) |
| Return on assets | (13.15%) | 12.88% | (19.72%) |
| Return on invested capital | (4.99%) | 5.62% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack